600 patients66,869 observations120 daysLIVE

Patient P-01503

Synthetic patientNBL-101 · Day 111 · 25–34 · F · baseline S15Open companion preview
Therapy response
Favorable
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
51%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S15
  2. Day 17 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 34 ME-01 recommendedMonitoring Escalation ME-01
  4. Day 35 Patient acceptedStarted ME-01 in the companion
  5. Day 38 Deterioration detected before clinical escalationMonitoring Escalation ME-01

What changed?

Trajectory began diverging from predicted response on Day 17.

Primary contributors, last 14 days
  • GI instability+25
  • Nutritional resilience-13
  • Inflammatory activity+5
  • Treatment adherence+3
  • Toxicity+3

What helped?

  • Monitoring Escalation ME-01Day 34
    Result: deterioration detected before clinical escalation
LIFE OS recommendation
Clinician Review CR-01
72%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 100% showed improvement
  • median effect visible after 5 days

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Inflammatory signalling 25
    • DNAIL6 -174 variant raises baseline inflammatory tone
DNA
Fictional pharmacogenomic panel
  • IL6 -174 G/C
    Higher inflammatory tone
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 4.4 · butyrate capacity 60/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisNormal
  • Bifidobacterium longumLow
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
44 ms
Sleep
6.7 h
Steps
9,730
Resting HR
65 bpm
Daily log: GI score 31, nutritional resilience 56, adherence 96.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Keep fibre steady; no new sources this week
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0180348%S1181
P-0170047%S0977
P-0166445%S0380
P-0167645%S0381
P-0175845%S1380
P-0189645%S0775
P-0130844%S0477
P-0132444%S0283
P-0132944%S08BR-03improved79
P-0144844%S1083
P-0147144%S1979
P-0152544%S1982